Cleared Traditional

ENDOFLIP CATHETER (K130906) - FDA 510(k) Clearance

Class II Gastroenterology & Urology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K130906 · Crospon, Ltd. · Gastroenterology & Urology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2013
Decision
107d
Days
Class 2
Risk

K130906 is an FDA 510(k) clearance for the ENDOFLIP CATHETER. Classified as System, Gastrointestinal Motility (electrical) (product code FFX), Class II - Special Controls.

Submitted by Crospon, Ltd. (Bonita Springs, US). The FDA issued a Cleared decision on July 17, 2013 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Gastroenterology & Urology FDA review panel, regulated under 21 CFR 876.1725 - the FDA gastroenterology and urology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Gastroenterology & Urology review framework, consistent with the majority of Class II 510(k) submissions.

View all Crospon, Ltd. devices

Submission Details

510(k) Number K130906 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 01, 2013
Decision Date July 17, 2013
Days to Decision 107 days
Submission Type Traditional
Review Panel Gastroenterology & Urology (GU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
23d faster than avg
Panel avg: 130d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FFX System, Gastrointestinal Motility (electrical)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1725
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Gastroenterology & Urology devices follow this clearance model.

Regulatory Peers - FFX System, Gastrointestinal Motility (electrical)

All 68
Devices cleared under the same product code (FFX) and FDA review panel - the closest regulatory comparables to K130906.
mcompass Anorectal Balloon Expulsion Catheter (RMD-003-001)
K252605 · Medspira, LLC · Dec 2025
Solar Compact (G4-1)
K240007 · Laborie Medical Technologies, Corp. · May 2024
EndoflipTM 300 System
K231861 · Covidien, LLC · Jul 2023
EndoflipTM 300
K223705 · Covidien, LLC · Apr 2023
Transit-Pellets
K222000 · Medifactia AB · Jan 2023
IntraMarX 3D Radiopaque Marker
K201106 · Anx Robotica Corp · May 2020